MERIDIAN BIOSCIENCE INC Annual Deferred Income Tax Expense (Benefit) in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Meridian Bioscience Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2022.
  • Meridian Bioscience Inc Deferred Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $216K, a 76.7% decline year-over-year.
  • Meridian Bioscience Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$1.1M, a 71.3% increase from 2021.
  • Meridian Bioscience Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$3.84M, a 605% decline from 2020.
  • Meridian Bioscience Inc annual Deferred Income Tax Expense (Benefit) for 2020 was $760K.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.